Allocell®

Allocell Premium Allograft Bone Graft
for Spinal Fusion

implant ready fibers illustration

MF

The implant-ready fibers require no prior preparation, offering an efficient solution for the management of small bony voids. The design makes them well-suited for minimally invasive techniques and procedures performed through limited surgical access.

graft material allocell

AF

The graft material is designed to address large bony voids and high-volume procedural requirements, making it well-suited for use in posterolateral gutters as well as within cages featuring large graft windows.

allocell syringe image

FLOWABLE

The 100% bone fiber DBM provides inherent osteoinductive properties while supporting bone growth through an osteoconductive scaffold. Convenient open-barrel syringe for ease of preparation and precise placement.

allocell strip material image

STRIP

The material provides an osteoconductive scaffold with growth factors and can be combined with autograft or other biologics at the surgeon’s discretion. It is easily hydrated and moldable to the desired shape, with a sterile assurance level of 10⁻⁶ to minimize infection risk.

Introducing

Allocell® LIVE

Our new viable bone matrix allograft representing the latest advancement in cellular bone technology. The graft offers an exceptional alternative to autograft through its osteoconductive, osteoinductive, and osteogenic potential. Our proprietary processing methods protect the native elements of bone, including growth factors and viable cells, while our advanced Clearant® fiber technology creates exceptional handling characteristics.

Osteoinductive Potential

Patented demineralization procedure effectively exposes and preserves endogenous growth factors within cortical tissue.

Osteogenic Potential

Proprietary processing removes blood and marrow while retaining viable cells bound to the native bone structures.

Osteoconductive

Interconnected fiber matrix and trabecular cancellous structure create a robust scaffold.

Fiber Bone Matrix

Allocell® AF and MF products are manufactured utilizing a process that provides for graft consistency in hydration, moldability, osteoconductive and osteoinductive potential. The Allocell process provides for a graft with optimal fluid retention and irrigation resistance.

Precise handling with the 2 options of fibers, Allocell® AF and MF allow the surgeon the capability for precise placement as well as retention at the graft site.

Our Allocell® demineralized bone fibers are made from 100% human tissue and designed for surgeons who want maximum osteoconductive and osteoinductive potential with fewer post-surgical complications.

Allocell® is a second-generation allograft with proprietary narrow and wide elongated inductive fibers interconnected in a weave that provides more continuous surface area for cellular attachment and proliferation

fiber bone matrix example image
fiber bone matrix allocell use

Want more information on Allocell®? Submit the quick contact form and our product specialists will get back to you right away!

allocell Allocell Premium Allograft Bone Graft for Spinal Fusion​ product image

Allocell Product FAQ

What is Allocell® MF composed of?

Demineralized osteoinductive human cortical bone fibers processed into a shorter fiber length. Made from 100% human tissue. The fibers are interconnected in a weave that provides continuous surface area for cellular attachment and proliferation.

The fibers are hydrated with blood, marrow, or saline to create a bone graft matrix for bony voids in the human anatomy. The implant-ready design requires no prior preparation, offering an efficient solution for the management of small bony voids.

Easily implanted in the posterolateral gutters, interbody disc space, or in an interbody cage for spinal fusion procedures. The design makes it well-suited for minimally invasive techniques and procedures performed through limited surgical access.

Processed utilizing Ventris’ proprietary Clearant® process to ensure the highest standards for quality and handling. The Allocell process provides graft consistency in hydration, moldability, osteoconductive potential, and osteoinductive potential.

MF has shorter cortical fibers to enable flowability and ease of packing into cages or small bony voids. AF uses longer fibers for large bony voids and high-volume procedures. Both variants share the same second-generation allograft technology with proprietary inductive fibers interconnected in a weave.

2.5, 5, 10, and 15 cc. The full size range supports selection based on graft volume and procedural need.

Less than 20 seconds. The rapid hydration supports efficient handling in the operating room.

Packaged in a clear jar, ready for hydration and use directly from the container. The design allows the surgeon to prepare and deliver the graft without additional transfer steps.

Sterile saline, blood, bone marrow aspirate, or bone marrow concentrate. The Allocell process provides optimal fluid retention and irrigation resistance regardless of the fluid chosen.

What is Allocell® AF composed of?

Demineralized osteoinductive human cortical bone fibers processed into a longer fiber length with an enhanced surface architecture. The proprietary wide and elongated inductive fibers are interconnected in a weave that provides continuous surface area for cellular attachment and proliferation.

Used primarily in the posterolateral gutters and interbody cages with large graft windows. The graft material is designed to address large bony voids and high-volume procedural requirements.

Easily implanted in the posterolateral gutters, interbody space, interbody cages, and bony voids in the human anatomy. The design gives the surgeon precise placement and retention at the graft site.

Manufactured and packaged under controlled aseptic conditions in an ISO Class 5 environment utilizing Ventris’ proprietary Clearant® process. The Allocell process provides graft consistency in hydration, moldability, osteoconductive potential, and osteoinductive potential.

2.5, 5, and 10 cc. The volume options align with the large bony void and high-volume procedures the AF variant is designed for.

Under 30 seconds. The rapid hydration supports efficient handling and delivery to the graft site.

Packaged and nested in a clear jar, ready for hydration and use. The design eliminates the need for additional transfer steps between package and graft site.

Sterile saline, blood, bone marrow aspirate, or bone marrow concentrate. The Allocell process provides optimal fluid retention and irrigation resistance regardless of the fluid chosen.

What is Allocell® Flowable composed of?

100% demineralized human cortical bone fibers suspended in a bone gelatin matrix. The DBM provides inherent osteoinductive properties while supporting bone growth through an osteoconductive scaffold.

Used in minimally invasive procedures and any procedure requiring flowable capacity. The open-barrel syringe supports ease of preparation and precise placement.

Placement into the posterolateral gutters, interbody cages, interbody space, and bony voids in the human anatomy. The flowable form factor lets the surgeon fill irregular graft site geometries without repacking.

Processed utilizing Ventris’ proprietary Clearant® process to ensure the highest standards for quality and handling. The processing preserves the osteoinductive properties of the demineralized cortical bone fibers.

In a syringe. The product can be expelled from an open barrel or through a luer cap attached to a bone graft delivery tube. This flexibility supports both direct placement and minimally invasive tube-based delivery.

1, 2.5, 5, and 10 cc. The size range supports procedures from small bony voids to larger graft volumes.

What is Allocell® Strip composed of?

100% human demineralized cancellous bone sponge. The material provides an osteoconductive scaffold with growth factors and can be combined with autograft or other biologics at the surgeon’s discretion.

Utilized in any bony void in the human anatomy. Once hydrated, it is moldable to the desired shape at the graft site.

Used in a variety of orthopedic, spine, and traumatic fusion procedures. The sponge form factor conforms to irregular graft site geometries during placement.

Processed utilizing Ventris’ proprietary Clearant® process to ensure the highest standards for quality and handling. The strip is sterilized to a sterile assurance level of 10⁻⁶ to minimize infection risk.

50 x 20 x 5 mm. The strip form is suitable for a range of orthopedic, spine, and traumatic fusion applications.

5-10 minutes using saline, blood, bone marrow aspirate, or bone marrow concentrate. Once hydrated, the strip is moldable to the desired shape at the graft site.

What is Allocell® LIVE composed of?

Cancellous bone combined with demineralized bone fibers and demineralized cortical bone powder, cryopreserved with a 0% DMSO cryopreservation solution. This viable bone matrix allograft represents the latest advancement in cellular bone technology from Ventris.

After thawing, it is used in bony voids for fusion in the human skeletal system. The graft offers osteoconductive, osteoinductive, and osteogenic potential as an alternative to autograft.

Used in bone grafting procedures in combination with autologous bone or other allograft bone, or as a standalone bone graft. The interconnected fiber matrix and trabecular cancellous structure create a robust scaffold for bone integration.

Prepared from tissue procured from a deceased donor determined to be eligible based on donor screening and testing results, using aseptic surgical techniques. Ventris’ proprietary processing removes blood and marrow while retaining viable cells bound to the native bone structures.

Allocell® LIVE comes in an open-barrel syringe applicator. The syringe design supports precise placement of the graft material at the fusion site.

Delivered cryopreserved on dry ice. Cryopreservation protects the native elements of bone, including growth factors and viable cells.

1, 2.5, 5, and 10 cc. The size options let the surgeon match graft volume to procedural need.

Backpack®

Bone Graft
System

Amplify®

Surface Activated
Bone Graft Putty

Contour®

Moldable Bioactive
Bone Graft

Connext®

Surgical
Matrix

Cellesta®

Amniotic Membrane
Allograft